DARNITSA Trademark

Trademark Overview


On Tuesday, June 11, 2019, a trademark application was filed for DARNITSA with the United States Patent and Trademark Office. The USPTO has given the DARNITSA trademark a serial number of 79275945. The federal status of this trademark filing is REGISTERED as of Tuesday, January 12, 2021. This trademark is owned by PRIVATE JOINT STOCK COMPANY "PHARMACEUTICAL FIRM "DARNITSA". The DARNITSA trademark is filed in the Pharmaceutical Products category with the following description:

Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal,...
darnitsa

General Information


Serial Number79275945
Word MarkDARNITSA
Filing DateTuesday, June 11, 2019
Status700 - REGISTERED
Status DateTuesday, January 12, 2021
Registration Number6242068
Registration DateTuesday, January 12, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements


Description of MarkThe mark consists of the stylized word "DARNITSA".
Goods and ServicesAntiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Drugs for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal drinks; medicinal oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; Pre-filled syringes containing pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Air purifying preparations; food for babies; protein dietary supplements; Tissues impregnated with pharmaceutical lotions for treating dermatological conditions; Alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical preparations for medical purposes for the diagnosis of pregnancy; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical or veterinary purposes; surgical glues; surgical dressings; candy, medicated; candy for medical purposes; sanitary preparations for medical purposes; plasters for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY "PHARMACEUTICAL FIRM "DARNITSA"
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressUA

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY "PHARMACEUTICAL FIRM "DARNITSA"
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressUA

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressUA

Party NamePRIVATE JOINT STOCK COMPANY "PHARMACEUTICAL FIRM "DARNITSA"
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressUA

Trademark Events


Event DateEvent Description
Thursday, August 3, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 30, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 13, 2021GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, April 13, 2021GENERIC MADRID TRANSACTION CREATED
Monday, April 12, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 12, 2021REGISTERED-PRINCIPAL REGISTER
Friday, December 18, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Sunday, October 25, 2020NOTIFICATION PROCESSED BY IB
Wednesday, October 7, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 7, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 21, 2020EXAMINER'S AMENDMENT ENTERED
Monday, September 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 21, 2020EXAMINERS AMENDMENT E-MAILED
Monday, September 21, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, September 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020ASSIGNED TO LIE
Thursday, August 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 28, 2020REFUSAL PROCESSED BY IB
Thursday, February 13, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 13, 2020REFUSAL PROCESSED BY MPU
Tuesday, January 14, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Monday, January 13, 2020NON-FINAL ACTION WRITTEN
Friday, January 10, 2020ASSIGNED TO EXAMINER
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 9, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB